Papillomavirus

A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study
A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test
Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population
Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study
HPV genotyping for the cross-sectional and longitudinal probability of developing CIN2
Impact of variations in triage cytology interpretation on human papillomavirus-based cervical screening and implications for screening algorithms
Implementation of DNA-HPV primary screening in Italian cervical cancer screening programmes. Results of the MIDDIR Project
Increasing trends in the incidence of potentially human papillomavirus-associated head neck cancer in italy (1988-2012)
Increasing trends in the incidence of potentially human papillomavirus-associated head neck cancer in italy (1988-2012)
Indicators for monitoring screening programs with primary hpv test
Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial
Nuove Tecnologie per il cancro della Cervice 2 (NTCC2): disegno dello studio e andamento del reclutamento
Risk of CIN2 or more severe lesions after negative HPV-mRNA E6/E7 overexpression assay and after negative HPV-DNA test: Concurrent cohorts with a 5-year follow-up
Screening women for cervical cancer carcinoma with a HPV mRNA test: first results from the Venice pilot program